No black box warning on record for Tamsulosin Hydrochloride

As of the latest FDA labeling reviewed, Tamsulosin Hydrochloride (TAMSULOSIN HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tamsulosin Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Advise patients about the possibility of symptoms related to postural hypotension and to avoid situations where injury could result should syncope occur (5.1) Should not be used in combination with strong inhibitors of CYP3A4. Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 p

No black box warning on record for Tamsulosin Hydrochloride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Advise patients about the possibility of symptoms related to postural hypotension and to avoid situations where injury could result should syncope occur (5.1) Should not be used in combination with strong inhibitors of CYP3A4. Use with caution in combination with moderate inhibitors of CYP3A4, with strong or moderate inhibitors of CYP2D6, in patients known to be CYP2D6 p

Tamsulosin Hydrochloride Black Box Warning

No black box warning on record for Tamsulosin Hydrochloride

Other warnings & precautions

Tamsulosin Hydrochloride Black Box Warning

No black box warning on record for Tamsulosin Hydrochloride

Other warnings & precautions